Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_3
1
14%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Terminated(3)
Other(3)

Detailed Status

unknown3
Terminated2
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (16.7%)
N/A5 (83.3%)

Trials by Status

unknown343%
withdrawn114%
not_yet_recruiting114%
terminated229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7